Mobile communication system providing for coexistence of both a cellular
automobile telephone system and a micro cellular system
    42.
    发明授权
    Mobile communication system providing for coexistence of both a cellular automobile telephone system and a micro cellular system 失效
    提供蜂窝汽车电话系统和微蜂窝系统两者共存的移动通信系统

    公开(公告)号:US5655216A

    公开(公告)日:1997-08-05

    申请号:US254588

    申请日:1994-06-06

    IPC分类号: H04W16/32 H04Q7/00

    CPC分类号: H04W16/32

    摘要: A mobile communication system is provided for increasing the capacity for personal stations and ensuring a radio channel for use with a micro cellular system irrespective of the environment in which the system is installed. In the mobile communication system which allows the coexistence of a cellular automobile telephone system and a micro cellular system, communications in the cellular automobile telephone systems and the micro cellular systems are performed in a digital form, and a personal station accessing to each of these systems is connected thereto by using a time-division multiplex access mode or a code division multiplex access mode. Since the time-division multiplex access mode or code division multiplex access mode is used, a radio channel at the same frequency can be used by a plurality of personal stations. Thus, the capacity of the system can be increased for personal stations without extending a used frequency band.

    摘要翻译: 提供移动通信系统,用于增加个人站的容量并确保与微蜂窝系统一起使用的无线电信道,而与系统安装的环境无关。 在允许蜂窝汽车电话系统和微蜂窝系统共存的移动通信系统中,蜂窝汽车电话系统和微蜂窝系统中的通信以数字形式进行,并且访问这些系统中的每一个的个人站 通过使用时分多路复用接入模式或码分多址接入模式与其连接。 由于使用时分复用接入模式或码分多址接入模式,所以可以由多个个人站使用相同频率的无线信道。 因此,可以增加个人站的系统的容量,而不延长所使用的频带。

    9,11-Methano-13-aza-11a-carbathrombanoic acid analogues

    公开(公告)号:US4389413A

    公开(公告)日:1983-06-21

    申请号:US285723

    申请日:1981-07-22

    摘要: The 9,11-methano-13-aza-11a-carbathrombanoic acid analogues of the general formula: ##STR1## [wherein A represents ##STR2## (in which m is an integer of 1 to 6, the double bond between the carbon atoms in positions 5 and 6 in (iv) is in cis or trans-configuration or a mixture thereof and the phenylene group in (iv) represents o-, m- or p-phenylene), R.sup.1 represents a hydrogen atom or a straight- or branched-chain alkyl group of 1 to 12 carbon atoms, two R.sup.2 both represent hydrogen atoms or methyl groups, R.sup.3 represents a hydrogen atom or a hydroxy group, R.sup.4 represents a single bond or a straight- or branched-chain alkylene group of 1 to 5 carbon atoms, R.sup.5 represents(i) a straight- or branched-chain alkyl, alkoxy or alkylthio group of 1 to 8 carbon atoms,(ii) a cycloalkyl or cycloalkyloxy group of 4 to 7 carbon atoms being unsubstituted or substituted by at least one straight- or branched-chain alkyl group of 1 to 8 carbon atoms or ##STR3## in which Z represents a single bond, an oxygen atom or a sulfur atom and R.sup.6 may occupy any of the free positions on the phenyl ring and represents a hydrogen atom, a halogen atom, a hydroxy group, a straight- or branched-chain alkyl or alkoxy group of 1 to 5 carbon atoms, a trihalomethyl group, an amino group or a mono- or dialkyl-amino group of 1 to 5 carbon atoms)and the wavy line attached to the carbon atom in position 15 represents .alpha.- or .beta.-configuration or a mixture thereof, provided that, when R.sup.3 represents a hydroxy group and R.sup.4 represents a single bond, R.sup.5 does not represent an alkoxy group, an alkylthio group, a cycloalkyloxy group, a phenoxy group and a phenylthio group],and cyclodextrin clathrates thereof, and when R.sup.1 represents a hydrogen atom, non-toxic salts thereof, possess strong inhibitory activities on platelet aggregation and on aorta contraction, and are useful for prevention and treatment of diseases which are induced by thromboxane A.sub.2.

    Polyvinyl (dialkylthiocarbamoylthio)acetate resin, method for producing
same and heavy metals-removing agent comprising same
    46.
    发明授权
    Polyvinyl (dialkylthiocarbamoylthio)acetate resin, method for producing same and heavy metals-removing agent comprising same 失效
    聚乙烯基(二烷基硫代氨基甲酰硫基)乙酸酯树脂,其制备方法和包含其的重金属去除剂

    公开(公告)号:US4239865A

    公开(公告)日:1980-12-16

    申请号:US849923

    申请日:1977-11-09

    摘要: A new polyvinyl(dialkylthiocarbamoylthio)acetate resin expressed by the formula ##STR1## (wherein R.sub.1 and R.sub.2 each represent hydrogen atom or an alkyl group of C.sub.1 -C.sub.5) is provided.Said resin has a superior heavy metals-removing performance and is insoluble in organic solvents and hence very useful as an agent for removing heavy metals.Said resin is prepared by reacting a tetraalkylthiuramdisulfide expressed by a formula ##STR2## (wherein R.sub.3, R.sub.4, R.sub.5 and R.sub.6 each represent hydrogen atom or an alkyl group of C.sub.1 -C.sub.5) with a vinyl acetate polymer on heating in a solvent.Said resin is used as an agent for removing heavy metals, alone or in admixture with an auxiliary agent such as active carbon.

    摘要翻译: 提供了由式(IMAGE)表示的新的聚乙烯基(二烷基硫代氨基甲酰硫基)乙酸酯树脂(其中R1和R2各自表示氢原子或C1-C5的烷基)。 所述树脂具有优异的重金属去除性能,并且不溶于有机溶剂,因此作为除去重金属的试剂非常有用。 所述树脂通过在溶剂中加热使由式(IMAGE)表示的四烷基秋兰姆二硫化物(其中R 3,R 4,R 5和R 6各自表示氢原子或C 1 -C 5烷基)与乙酸乙烯酯聚合物反应制备。 所述树脂用作单独或与助剂如活性炭混合的重金属去除剂。

    15-Cycloalkyl-prostaglandin derivatives
    47.
    发明授权
    15-Cycloalkyl-prostaglandin derivatives 失效
    15-环烷基 - 前列腺素衍生物

    公开(公告)号:US4180675A

    公开(公告)日:1979-12-25

    申请号:US857341

    申请日:1977-12-05

    摘要: The present invention relates to 15-cycloalkyl-prostaglandins of the formula: ##STR1## wherein A represents a grouping of the formula: ##STR2## W represents ethylene or trans-vinylene, X represents ethylene or cis-vinylene, Y represents ethylene or trans-vinylene, R represents a hydrogen atom or a straight- or branched-chain alkyl group containing from 1 to 12 carbon atoms, R.sup.1 represents a hydrogen atom or a methyl or ethyl group, R.sup.2 represents a straight- or branched-chain alkyl group containing from 2 to 8 carbon atoms or a phenyl group unsubstituted or substituted by an alkyl group containing from 1 to 3 carbon atoms, R.sup.3 represents a hydrogen atom or a straight- or branched-chain alkyl group containing from 1 to 3 carbon atoms, and n represents 4 or 5 and cyclodextrin clathrates of such acids and esters and, when R represents a hydrogen atom, non-toxic salts thereof.These new compounds exhibit characteristic prostaglandin-like activities.

    摘要翻译: 本发明涉及下式的15-环烷基 - 前列腺素:其中A表示下式的基团:W表示亚乙基或反式亚乙烯基,X表示亚乙基或顺式亚乙烯基,Y表示亚乙基或反式亚乙烯基 - 亚乙烯基,R表示氢原子或含有1至12个碳原子的直链或支链烷基,R1表示氢原子或甲基或乙基,R2表示直链或支链烷基, 2至8个碳原子的苯基或未被取代或被含有1至3个碳原子的烷基取代的苯基,R 3表示氢原子或含有1至3个碳原子的直链或支链烷基,n 代表这些酸和酯的4或5和环糊精包合物,当R代表氢原子时,其无毒性盐。 这些新化合物表现出特征性的前列腺素样活性。

    .DELTA..sup.3 -Prostaglandin analogs
    48.
    发明授权
    .DELTA..sup.3 -Prostaglandin analogs 失效
    {66 {HU 3 {B-前列腺素类似物

    公开(公告)号:US4145555A

    公开(公告)日:1979-03-20

    申请号:US774828

    申请日:1977-03-07

    摘要: The present invention relates to prostaglandin analogues of the general formula: ##STR1## �wherein X represents cis or trans-vinylene or ethylene, Z represents ##STR2## R.sup.1 represents a hydrogen atom or a straight- or branched-chain alkyl group containing from 1 to 12 carbon atoms, R.sup.2 represents a hydrogen atom or a methyl group, R.sup.3 represents a straight- or branched-chain alkylene group containing from 1 to 7 carbon atoms and R.sup.4 represents a cycloalkyl group containing from 5 to 7 carbon atoms, a grouping of the formula: ##STR3## (wherein R.sup.5 and R.sup.6, which may be the same or different, each represent a hydrogen atom or halogen atom, a trifluoromethyl group or a straight- or branched-chain alkyl group containing from 1 to 4 carbon atoms), or a grouping of the formula: ##STR4## (wherein R.sup.5 and R.sup.6 are as hereinbefore defined), or R.sup.3 and R.sup.4 together represent a straight- or branched-chain alkyl group containing from 1 to 10 carbon atoms, and (1) the double bond between C.sub.3 -C.sub.4 is trans or cis, or trans and cis, when X is cis-vinylene or ethylene, and (2) the double bond between C.sub.3 -C.sub.4 is trans, when X is trans-vinylene, and the double bond between C.sub.13 -C.sub.14 is trans! and cyclodextrin clathrates of such acids and esters, and when R.sup.1 represents a hydrogen atom, non-toxic salts thereof, which exhibit characteristic prostaglandin-like activities.

    摘要翻译: 本发明涉及以下通式的前列腺素类似物:其中X表示顺式或反式亚乙烯基或亚乙基,Z表示R 1表示氢原子或含有1个或更多个的直链或支链烷基 至12个碳原子,R 2表示氢原子或甲基,R 3表示含有1至7个碳原子的直链或支链亚烷基,R 4表示含有5至7个碳原子的环烷基, 式(其中R5和R6可以相同或不同,分别表示氢原子或卤原子,三氟甲基或含有1至4个碳原子的直链或支链烷基) ,或下式的分组:其中R 5和R 6如上所定义,或者R 3和R 4一起表示含有1至10个碳原子的直链或支链烷基,和(1) C3-C4之间的双键是反式或顺式,或 反式和顺式,当X为顺式 - 亚乙烯基或亚乙基时,和(2)当X为反式亚乙烯基时,C 3 -C 4之间的双键为反式,C13-C14之间的双键为反式]和环糊精包合物 酸和酯,当R1代表氢原子时,其无毒性盐显示出特征性的前列腺素样活性。

    15-Cycloalkyl-prostaglandin derivatives
    49.
    发明授权
    15-Cycloalkyl-prostaglandin derivatives 失效
    15-环烷基 - 前列腺素衍生物

    公开(公告)号:US4087620A

    公开(公告)日:1978-05-02

    申请号:US703158

    申请日:1976-07-07

    摘要: The present invention relates to 15-cycloalkyl-prostaglandins of the formula: ##STR1## WHEREIN A represents a grouping of the formula: ##STR2## W represents ethylene or trans-vinylene, X represents ethylene or cis-vinylene, Y represents ethylene or trans-vinylene, R represents a hydrogen atom or a straight- or branched-chain alkyl group containing from 1 to 12 carbon atoms, R.sup.1 represents a hydrogen atom or a methyl or ethyl group, R.sup.2 represents a straight- or branched-chain alkyl group containing from 2 to 8 carbon atoms or a phenyl group unsubstituted or substituted by an alkyl group containing from 1 to 3 carbon atoms, R.sup.3 represents a hydrogen atom or a straight- or branched-chain alkyl group containing from 1 to 3 carbon atoms, and n represents 4 or 5) and cyclodextrin clathrates of such acids and esters and, when R represents a hydrogen atom, non-toxic salts thereof.These new compounds exhibit characteristic prostaglandin-like activities.

    摘要翻译: 本发明涉及下式的15-环烷基 - 前列腺素:其中A表示下式的基团:W表示亚乙基或反 - 亚乙烯基,X表示亚乙基或顺式 - 亚乙烯基,Y表示亚乙基或反式 - 亚乙烯基,R表示氢原子或含有1至12个碳原子的直链或支链烷基,R1表示氢原子或甲基或乙基,R2表示直链或支链烷基, 2至8个碳原子的苯基或未被取代或被含有1至3个碳原子的烷基取代的苯基,R 3表示氢原子或含有1至3个碳原子的直链或支链烷基,n 代表4或5)和这些酸和酯的环糊精包合物,当R代表氢原子时,其无毒性盐。

    16-Phenoxy and phenylthio prostaglandin derivatives
    50.
    发明授权
    16-Phenoxy and phenylthio prostaglandin derivatives 失效
    16-苯氧基和苯硫基前列腺素衍生物

    公开(公告)号:US4065632A

    公开(公告)日:1977-12-27

    申请号:US713941

    申请日:1976-08-12

    摘要: The present invention relates to compounds of the formula: ##STR1## wherein A represents a grouping of the formula: ##STR2## B represents an oxygen or sulphur atom, R.sup.1 and R.sup.2, which may be the same or different, each represent a hydrogen or halogen atom, a trifluoromethyl group, or a straight- or branched-chain alkyl or alkoxy group containing from 1 to 4 carbon atoms, R represents a group of the formula --COOR.sup.3, in which R.sup.3 represents a hydrogen atom or a straight- or branched-chain alkyl group containing from 1 to 12 carbon atoms, or a group of the formula --CH.sub.2 OR.sup.4, in which R.sup.4 represents a hydrogen atom or an alkylcarbonyl group containing from 2 to 5 carbon atoms and the double bonds depicted in positions C.sub.2 -C.sub.3, C.sub.5 -C.sub.6 and C.sub.13 -C.sub.14 are trans, cis and trans respectively, the cyclodextrin clathrates thereof and, when R.sup.3 in the group --COOR.sup.3 represents a hydrogen atom, non-toxic salts thereof. These compounds exhibit characteristics of prostaglandin-like activity.

    摘要翻译: 本发明涉及下式的化合物:其中A表示下式的基团:IV B表示氧或硫原子,R 1和R 2可以是 相同或不同,各自表示氢或卤素原子,三氟甲基或含有1至4个碳原子的直链或支链烷基或烷氧基,R表示式-COOR 3的基团,其中R 3 表示氢原子或含有1至12个碳原子的直链或支链烷基,或式-CH 2OR 4基团,其中R 4表示氢原子或含有2至5个碳原子的烷基羰基, 位置C2-C3,C5-C6和C13-C14中所示的双键分别是反式,顺式和反式,环糊精包合,当-COOR3基团中的R3表示氢原子时,其无毒盐。 这些化合物表现出前列腺素样活性的特征。